Costs of pediatric community-acquired rotavirus gastroenteritis in Italy (Padua county);Costi della gastroenterite da rotavirus acquisita in comunità in età pediatrica a Padova in Italia

PharmacoEconomics - Italian Research Articles

Volumn 9, Issue 2, 2007, Pages 103-111

  Giaquinto, Carlo ^a,d   Callegaro, S ^a   Andreola, B ^a   Bernuzzi, M ^b   Cantarutti, L ^b   D'Elia, R ^a   Drago, S ^b   De Marchi, A ^b   Falconi, P ^b   Felice, M ^b   Giancola, G ^b   Lista, C ^b   Manni, C ^b   Perin, M ^b   Pisetta, F ^b   Scamarcia, A ^b   Sidran, M P ^b   Largeron, N ^c   Trichard, M ^c   Da Dalt, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Family Paediatricians Pedianet Rotavirus Study Group

^c SANOFI PASTEUR   (France)

^d Dipartimento di Pediatria   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ABSENTEEISM; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMERGENCY WARD; GASTROENTERITIS; HEALTH CARE COST; HEALTH SERVICE; HOSPITAL; HUMAN; ITALY; MAJOR CLINICAL STUDY; PEDIATRICS; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; ROTAVIRUS; VACCINATION;

EID: 34748831158     PISSN: 15909158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03320704     Document Type: Article

References (33)

1. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhoea. Emerg Infect Dis 2006; 12: 304-6
2. Clark HF, Offitt PA. Vaccines for Rotavirus gastroenteritis universally needed for children. Pediatr Ann 2004; 338: 537-43
3. The Pediatric ROTavirus European CommitTee (PROTECT). The paediatric burden of rotavirus disease in Europe. Epidemiol Infect 2006; 134: 908-16
4. Soriano-Gabarro M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006; 25 (1 Suppl.): S7-11
5. Giaquinto C, Callegaro S, Andreola B, et al. Prospective study of the burden of acute gastroenteritis in children less than 5 years in Italy. Riv Ital Pediatr 2007, in corso di stampa
6. Vesikari T, Matson DO, Dennehy P, et al. (Rotavirus Efficacy and Safety Trial Study Team). Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33
7. Ruiz-Palacios GM, Pérez-Schael I, Velasquez FR, et al. (Human Rotavirus Vaccine Group Study). Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22
8. Van Damme P, Van der Wielen M, Ansaldi F, et al. Rotavirus vaccines: considerations for successful implementation in Europe. Lancet Infect Dis 2006; 6: 805-12
9. Piednoir E, Bessaci K, Bureau-Chalot F, et al. Economic impact of healthcare associated rotavirus infection in a pediatric hospital. J Hosp Infect 2003; 55: 190-5
10. Fruhwirth M, Berger K, Ehlken B, et al. Economic impact of community and nosocomially acquired Rotavirus gastroenteritis in Austria. Pediatr Infect Dis J 2001; 20: 184-8
11. Vesikari T, Rautanen T, Von Bonsdorff CH. Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features. Acta Paediatr Suppl 1999; 88: 24-30
12. Visser LE, Portero RC, Gay NJ, Navarro JFM. Impact of rotavirus disease in Spain: an estimate of hospital admissions due to rotavirus. Acta Paediatr Suppl 1999; 88: 72-6
13. Fontana M, Zuin G, Pancheri P, et al. Costs associated with outpatients diarrhoea in infants and toddlers: a nationwide study
14. of Italian Society of Pediatric Gastroenterology and Hepatology (SIGEP). Dig Liver Dis 2004; 36: 523-7
15. Lorgelly PK, Joshi D, Iturriza Gómara M, et al. Infantile gastroenteritis in the community: a cost of illness study. Poster presented at the 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases. Valencia, Spain, May 18-20, 2005.
16. Melliez H, Boelle P-Y, Baron S, et al. Morbidity and cost of rotavirus infections in France [in French]. Méd Mal Infect 2005; 35: 492-9
17. Roberts JA, Cumberland P, Sockett PN, et al. The study of infectious intestinal disease in England: socio-economic impact. Epidemiol Infect 2003; 130: 1-11
18. Hammerschmidt T, Gartner B. Acute Rotavirus Gastroenteritis: burden of disease and cost of illness among young children in Germany. Value Health 2004; 7: 762
19. Johansen K, Bennet R, Bondesson K, et al. Incidence and estimates of the disease burden of rotavirus in Sweden. Acta Paediatr Suppl 1999; 88: 20-3
20. Takala AK, Koskenniemi E, Joensuu J, et al. Economic evaluation of Rotavirus vaccinations in Finland: randomized, double-blind, placebo controlled trial of tetravalent rhesus rotavirus vaccine. Clin Infect Dis 1998; 88: 24-30
21. Van Damme P, Giaquinto C, Huet F, et al. Multicentre prospective study of the burden of rotavirus acute gastroenteritis in Europe 2004-2005: the REVEAL Study. J Infect Dis 2007; 195 (Suppl. 1): S1-6
22. Giaquinto C, Van Damme P, Huet F, et al. Clinical impact of rotavirus acute gastroenteritis in Europe 2004-2005: the REVEAL Study. J Infect Dis 2007; 195 (Suppl. 1): S26-35
23. Ward RL, McNeal MM, Clemens JD, et al. Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J Clin Microbiol 1991; 29: 449-56
24. Ministem della Salute. Aggiornamento delle tariffe delle prestazioni di assistenza ospedaliera di cui al DM 14.12.1994; DM 30.6.1997, suppl. ord. GU n. 209 dell'8.9.1997
25. Coudeville L, Brunot A, Giaquinto C, et al. Varicella vaccination in Italy: an economic evaluation of different scenarios. Pharmacoeconomics 2004; 22: 839-55
26. Lucioni C, Garancini MP, Massi-Benedetti M, et al. Il costo sociale del diabete di tipo 2 in Italia: lo studio CODE-2. Pharmacoeconomics-Italian Research Articles 2000; 2: 1-21
27. Ministero della Salute. Tariffe Nazionali Ambulatoriali. DM 22.7.1996, GU n. 216 del 4.11.1996
28. Banca d'ltalia. Assemblea generale ordinaria dei partecipanti, 31 maggio 2005
29. Lucioni C, Alliata E, Mazzi S, Lizioli A. I costi della meningite pneumococcica in età pediatrica. Pharmacoeconomics-Italian Research Articles 2005; 7: 177-86
30. Ministero della Salute. Diagnosis Related Groups. www.drg.it
31. World Health Organization. The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD) www.who.int/ classifications/atcddd/en/.
32. Giaquinto C, Van Damme P, Huet F, et al. Cost of community acquired pediatric Rotavirus gastroenteritis in seven European countries: the REVEAL study. J Infect Dis 2007; 195 (Suppl. 1): S36-44
33. UNICEF, Italy (2004) www.unicef.org/infobycountry/italy.html